Skip to main content
. 2022 Sep 14;7(9):1713–1724. doi: 10.1182/bloodadvances.2022008292

Figure 2.

Figure 2.

OS of patients by subtype of MCL. Kaplan-Meier estimates of OS for (A) the full cohort of patients with MCL (n = 92) and stratified by (B) MCL vs MCL-AHN; (C) chronic vs acute MCL; (D) de novo vs secondary MCL; (E) normal vs abnormal karyotype; and (F) any vs no PB MCs.